Self-Help MGH Substance Use Disorders: A comprehensive Update, Orlando, 2016
|
|
- Leslie Murphy
- 5 years ago
- Views:
Transcription
1 Self-Help John F. Kelly, Ph.D. Elizabeth R. Spallin Associate Professor in Psychiatry Harvard Medical School Director Recovery Research Institute Program Director Addiction Recovery Management Service Associate Director MGH Center for Addiction Medicine MGH Substance Use Disorders: A comprehensive Update, Orlando, 2016
2 Disclosures Neither I nor my spouse/partner has a relevant financial relationship with a commercial interest to disclose.
3 Overview 1. Background and Rationale: Why selfhelp ( mutual-help )? 2. Efficacy and Mechanisms: Do groups like AA confer real benefits? If so, how? 3. Clinical Interventions: What can we do clinically to enhance self-help participation and enhance outcomes?
4 Overview 1. Background and Rationale: Why selfhelp ( mutual-help )? 2. Efficacy and Mechanisms: Do groups like AA confer real benefits? If so, how? 3. Clinical Interventions: What can we do clinically to enhance self-help participation and enhance outcomes?
5 1. Why Self-help? Key Points Achieving stabilization and recovery is stressful Addiction is susceptible to relapse over the longterm MHOs like AA are widely available - provide adaptive long-term indigenous community recovery support for free
6 CBT MI TSF
7 Key: PFC prefrontal cortex; ACG anterior cingulate gyrus; OFC orbitofrontal cortex; SCC subcallosal cortex; NAc nucleus accumbens; VP ventral pallidum; Hipp hippocampus; Amyg amygdala. 7
8 8
9 Protracted/post-acute withdrawal effects: More stress and lowered ability to experience normal pleasures Increased sensitivity to stress via Increased activity in hypothalamic-pituitaryadrenal axis (HPA-axis) and CRF/Cortisol release Lowered ability to experience normal levels of reward via Down-regulated dopamine D2 receptor activity increasing risk of protracted dysphoria/anhedonia
10 For more severely dependent individuals course of dependence and achievement of stable recovery can take a long time Addiction Onset Help Seeking Full Sustained Remission (1 year abstinent) Relapse Risk drops below 15% 4-5 years 8 years 5 years Opportunity for earlier detection through screening in non-specialty settings like primary care/ed Selfinitiated cessation attempts 4-5 Treatment episodes/ mutualhelp Continuing care/ mutualhelp 60% of individuals with addiction will achieve full sustained remission (White, 2013)
11 Potential Advantages of Community Mutual-help Cost-effective -free; attend as intensively, as long as desired Focused on addiction recovery over the long haul Widely available, easily accessible, flexible Access to fellowship/broad support network Entry threshold (no paperwork, insurance); anonymous (stigma) Adaptive community based system that is responsive to undulating relapse risk
12 Substance Focused Mutual-help Groups Name Year of Origin Number of groups in U.S. Location of groups in U.S. Evidence base* (0-3) Alcoholics Anonymous (AA) 1935 Narcotics Anonymous (NA) 1940s Cocaine Anonymous (CA) 1982 Methadone Anonymous (MA) 1990s Marijuana Anonymous (MA) 1989 Rational Recovery (RR) ,651 Approx. 15,000 Approx groups Approx. 100 groups Approx. 200 groups No group meetings or mutual helping; emphasis is on individual control and responsibility all 50 States 1, 2, 3 all 50 States 1, 2 most States; 6 online meetings at 25 States; online meetings at 24 States; online meetings at 0 1, , 2 0 Self-Management and Recovery Training (S.M.A.R.T. Recovery) 1994 Approx. 250 groups 40 States; 19 online meetings at 1, 3 Secular Organization for Sobriety, a.k.a. Save Ourselves (SOS) 1986 Approx. 480 groups all 50 States; Online chat at 1 Women for Sobriety (WFS) groups Online meetings at WomenforSobriety 1 Moderation Management (MM) 1994 Approx.16 face-to-face meetings 12 States; Most meetings are online at 1 *0= None 1=Descriptive studies only 2 = Observational (correlational, longitudinal) 3= Experimental (random assignment, controlled). Source: Kelly & Yeterian, 2008
13
14 Overview 1. Background and Rationale: Why selfhelp ( mutual-help )? 2. Efficacy and Mechanisms: Do groups like AA confer real benefits? If so, how? 3. Clinical Interventions: What can we do clinically to enhance self-help participation and enhance outcomes?
15 2. Do groups like AA actually confer real benefits? If so, how? Key Points MHOs, like AA, confer benefits that are on par in magnitude with professional interventions Interventions that promote MHO participation (i.e., TSF) often produce superior outcomes and higher rates of FSR Participation in MHOs reduces reliance on professional care, reduces health costs and enhances remission TSF/MHOs produce these better outcomes because they mobilize mechanisms mobilized by formal treatment (e.g., coping skills/motivation/abstinence self-efficacy)
16
17 T S F O T H TSF Delivery Modes Stand alone Independent therapy Integrated into an existing therapy Component of a treatment package (e.g., an additional group) As Modular appendage linkage component In past 25 years, AA research has gone from contemporaneous correlational research to rigorous RCTs and
18 (3-mo) AA attendance (15-mo) Alcohol Outcomes (PDA or DDD) Baseline (BL) Covariates Age Race Sex Marital Status Employment Status Prior Alcohol Treatment MATCH Treatment group MATCH study site and lagged moderated multiple mediation studies to elucidate its impact and MOBCs Alcohol Outcomes (PDA/DDD) (BL) Self-efficacy Negative Affect (BL) Self-efficacy Positive Social (BL) Religious/Spiritual Practices (BL) Depression (BL) Social Network pro-abstinence (BL) Social Network pro-drinking (9-mo) Self-efficacy Negative Affect (9-mo) Self-efficacy Positive Social (9-mo) Religious/Spiritual Practices (9-mo) Depression (9-mo) Social Network pro-abstinence (9-mo) Social Network pro-drinking Source: Kelly, Hoeppner, Stout, Pagano (2012), Determining the relative importance of the mechanisms of behavior change within Alcoholics Anonymous: A multiple mediator analysis. Addiction 107(2):289-99
19 T S F O T H TSF Delivery Modes Stand alone Independent therapy Integrated into an existing therapy Component of a treatment package (e.g., an additional group) As Modular appendage linkage component
20 TSF often produces significantly better outcomes relative to active comparison conditions (e.g., CBT) Although TSF is not AA, it s beneficial effect is explained by AA involvement post-treatment.
21 Also, state of the art instrumental variables analyses, as well as propensity score matching (Ye and Kaskutas, 2013) that help to remove selfselection biases, indicate AA has a causal impact on enhancing abstinence and remission rates.
22 % Participants % Participants Linkage to AA can lead to much higher rates of full sustained remission (Project MATCH, 1997) TSF treatment can lead to much higher rates of full sustained remission Continuous Abstinence Rates during year following treatment (4-15 Months) Continuous Abstinence Rates past 90 days- 3 Years TSF TSF CBT CBT MET MET 10 Treamtment Condition 10 Treamtment Condition
23
24 HEALTH CARE COST OFFSET CBT VS 12-STEP RESIDENTIAL TREATMENT $20,000 $18,000 $17,864 $16,000 $14,000 $12,129 $12,000 $10,000 $8,000 $5,735 $6,000 $4,000 $2,000 $0 CBT Humphrey and Moos, 2001, 2007 ; ACER $9,840 $7,400 $2,440 TSF Compared to CBT-treated patients, 12-step treated patients more likely to be abstinent, at a $8,000 lower cost per pt over 2 yrs ($10M total savings) Year 1 Year 2 Total Also, higher remission rates, means decreased disease and deaths, increased quality of life for sufferers and their families
25 Findings from meta-analyses Emrick et al studies. AA attendance and involvement modest beneficial effect on drinking behavior Tonigan et al., studies. Examined moderators of effectiveness (i.e. outpatient vs. inpatient; study quality) Studies generally, were methodological poor and underpowered Kownacki & Shadish, studies. Examined controlled trials only - Randomization confounded with coerced status (justice system required) - Coerced individuals fared worse than individuals in other treatment or no treatment - Coerced individuals may have better outcomes if coerced into other kinds of treatment - Found support for 12-step-based tx and non-coerced AA attendance
26 Ferri, Amato, Davoli (2006) (Cochrane Review) Attempted to examine RCTs of AA or TSF 8 trials involving 3417 people were included. Findings: AA may help patients to accept treatment and keep patients in treatment more than alternative treatments AA had similar retention rates 3 studies compared AA combined with other interventions against other treatments and found few differences in the amount of drinks and percentage of drinking days Peer-led AA participation and TSF found to be as effective as other comparison professionally-delivered interventions to which it was compared
27 Overview 1. Background and Rationale: Why selfhelp ( mutual-help )? 2. Efficacy and Mechanisms: Do groups like AA confer real benefits? If so, how? 3. Clinical Interventions: What can we do clinically to enhance self-help participation and enhance outcomes?
28 Curative factors of group therapy and of MHOs? Universality Altruism Instillation of hope Imparting information Recapitulation of the primary family experience Development of socializing techniques Imitative behavior Cohesiveness Existential factors Catharsis Interpersonal learning Self-understanding (Yalom, 1995)
29 (3-mo) AA attendance (15-mo) Alcohol Outcomes (PDA or DDD) Baseline (BL) Covariates Age Race Sex Marital Status Employment Status Prior Alcohol Treatment MATCH Treatment group MATCH study site Alcohol Outcomes (PDA/DDD) (BL) Self-efficacy Negative Affect (BL) Self-efficacy Positive Social (BL) Religious/Spiritual Practices (BL) Depression (BL) Social Network pro-abstinence (BL) Social Network pro-drinking (9-mo) Self-efficacy Negative Affect (9-mo) Self-efficacy Positive Social (9-mo) Religious/Spiritual Practices (9-mo) Depression (9-mo) Social Network pro-abstinence (9-mo) Social Network pro-drinking Source: Kelly, Hoeppner, Stout, Pagano (2012), Determining the relative importance of the mechanisms of behavior change within Alcoholics Anonymous: A multiple mediator analysis. Addiction 107(2):289-99
30 Do more and less severely alcohol dependent individuals benefit from AA in the same or different ways? Aftercare (PDA) SocNet: pro-drk. 24% SocNet: proabst. 16% Self-efficacy (NA) 5% Self-efficacy (Soc) 34% Spirit/Relig 23% Depression 3% effect of AA on alcohol use for AC was explained by social factors but also by S/R and through negative affect (DDD only) SocNet: pro-abst. 11% Aftercare (DDD) SocNet: pro-drk. 16% Self-efficacy (Soc) 21% Self-efficacy (NA) 20% Spirit/Relig 21% Depression 11% Self-efficacy (NA) 1% Outpatient (PDA) Depression 2% Spirit/Relig 6% Majority of effect of AA on alcohol use for OP was explained by social factors Self-efficacy (NA) 1% Outpatient (DDD) Depression 5% SocNet: pro-drk. 33% SocNet: proabst. 31% Self-efficacy (Soc) 27% SocNet: pro-drk. 29% SocNet: proabst. 17% Spirit/Relig 9% Self-efficacy (Soc) 39% Source: Kelly, Hoeppner, Stout, Pagano (2012), Determining the relative importance of the mechanisms of behavior change within Alcoholics Anonymous: A multiple mediator analysis. Addiction 107(2):
31 Do men and women benefit from AA in the same ways? 31
32 Empirically-supported MOBCs through which AA confers benefit Social network Spirituality Social Abstinence self-efficacy Coping skills Recovery motivation Negative Affect Abstinence selfefficacy Psychological Well-being Impulsivity Craving
33 Implications of Findings from 25 yrs of AA Mechanisms Research Results suggest the way AA works has closer fit with pragmatic social, cognitive, behavioral experiences of how its members stay sober documented in its later publications (Living Sober, 1975) written when AA numbered >1 million men + women (half with 5+ yrs of sobriety) than with the Big Book (1935; 2001), based on less than 100 all White, male, severely addicted cases, most with short lengths of sobriety. Consequently, the purported spiritual awakening deemed necessary for recovery, may have been true based on experience of initial very severe cases on which AA was based, and appears to be true of severe cases now, but the MOBC through which AA works has proven to be multifaceted
34 How might RSSs reduce relapse risk and aid recovery? Cue Induced Stress Induced Alcohol Induced CUES: -RSSs reduces relapse risks via social network changes that may reduce exposure to triggers and increase active coping and social ASE; MHOs may also reduce craving and impulsivity; STRESS: RSSs helps reduce stress induced relapse possibly via increased coping skills and spiritual Social framework and boosting negative affect ASE, particularly among women Psych ALCOHOL: RSSs may reduce alcohol induced relapse via Bio-Neuro reducing cravings, strong emphasis on abstinence (preventing priming dose exposure); boosting social and negative affect ASE RELAPSE RSS Kelly, JF Yeterian, JD In: McCrady and Epstein Addictions: A comprehensive Guidebook, Oxford University Press (2013) 34
35 Similar to the common finding that theoretically-distinct professional interventions do not result in differential patient outcomes, AA s effectiveness may not be due to its specific content or process. Rather, its chief strength may lie in its ability to provide free, long-term, easy access and exposure to recovery-related common therapeutic elements, the dose of which, can be adaptively selfregulated according to perceived need. (Kelly, Magill, Stout, 2009) Similar to psychotherapy literature rather than thinking about how AA or similar interventions work, better to think how individuals use or make these interventions work for them to meet most salient needs at any given phase of recovery
36 Does AA cause better outcomes or is AA participation an outcome of better prognosis? Using accepted scientific standards (Bradford Hill criteria) and the most rigorous scientific methods (i.e., RCTs, instrumental variables analysis, PS matching), evidence indicates causal therapeutic benefit of AA The one exception is specificity (e.g., other interventions could also cause these benefits) But given AA is available free of charge in practically every US community and that an intervention s Impact is a product of = reach x effectiveness (Glasgow et al, 2003), AA can be considered a clinical and public health ally in ameliorating the prodigious burden of disease attributable to alcohol addiction
37 Overview 1. Background and Rationale: Why selfhelp ( mutual-help )? 2. Efficacy and Mechanisms: Do groups like AA confer real benefits? If so, how? 3. Clinical Interventions: What can we do clinically to enhance self-help participation and enhance outcomes?
38 3. What can we do clinically to enhance self-help participation and thereby enhance clinical outcomes? Key points Broach the topic of MHO participation Discuss what to expect (if patient never been) Actively prescribe participation Link with active members whenever possible Monitor attendance and reaction
39 T S F O T H TSF Delivery Modes Stand alone Independent therapy Integrated into an existing therapy Component of a treatment package (e.g., an additional group) As Modular add-on linkage component
40 Strategies for Facilitating Outpatient Attendance of AA (Wallitzer et al, 2008) Approaches to assist in involvement in AA 169 adult alcoholic outpatients randomly assigned to one of three treatment conditions All clients received treatment that included: 12 sessions Focus on problem-solving, drink refusal, relaxation Recommendation to attend AA meetings
41 Strategies for Facilitating Outpatient Attendance of AA Treatment varied between 3 conditions in terms of how the therapist discussed AA and how much information about AA was shared Condition 1: Directive approach - Therapist directed - Client signed contract describing goals to attend AA meetings - Therapist encouraged client to keep a journal about meetings - Reading material about AA provided to client - Therapist informs client about skills to use during meetings and about using a sponsor - 38% total material covered in sessions was about AA Condition 2: motivational enhancement approach (more client centered) - Therapist obtains clients feelings and attitudes about AA - Therapist describes positive aspects of AA, but states that it is up to the client how much they will be involved - Therapist intends to assist the client in making a decision in favor of AA - 20% total material covered in sessions about AA Condition 3: CBT treatment as usual, no special emphasis on AA - Throughout treatment, therapist briefly inquires about AA and encourages client to attend AA - 8% total material covered in sessions about AA Walitzer, Dermen & Barrick, 2009
42 Strategies for Facilitating AA Attendance during Outpatient Treatment
43 Strategies for Facilitating AA Attendance during Outpatient Treatment
44
45
46 Summary 1. Background and Rationale: Why selfhelp ( mutual-help )? 2. Efficacy and Mechanisms: Do groups like AA confer real benefits? If so, how? 3. Clinical Interventions: What can we do clinically to enhance self-help participation and enhance outcomes?
47 Acknowledgements Colleagues Eden Evins, MD Bettina Hoeppner, PhD Brandon Bergman, PhD Post-Doc Fellows Allison Labbe, PhD Karen Urbanoski, PhD Corrie Vilsaint, PhD Interns David Eddie, MS Staff Julie Cristello, BA Sarah Dow, BS Nilo Fallah-Sohy, BS Claire Greene, MPH Veselina Hristova, MSW Nate Kelly, BA Julie Sloane, BA Jessica Kim, NP Erin Newman, LICSW Cristi O Connor, MHS Jonathan Watson, MA Julie Yeterian, MA Sources of Funding National Institute of Alcohol Abuse and Alcoholism/R21AA A1 National Institute of Mental Health/1R21MH A1 Recovery Research Institute, Private Donations National Institute of Alcohol Abuse and Alcoholism/R01AA A1 National Institute of Alcohol Abuse and Alcoholism/R01AA A1S1 Canadian Institute of Health Research/MOP National Institute of Alcohol Abuse and Alcoholism/K24AA Conflict of Interest None declared
48 Sign up for our free monthly Recovery Bulletin at:
Self Help. John F. Kelly, Ph.D.
Self Help John F. Kelly, Ph.D. www.recoveryanswers.org Disclosures Neither I nor my spouse/partner has a relevant financial relationship with a commercial interest to disclose. Overview 1. Background and
More informationSelf-Help MGH Substance Use Disorders: A comprehensive Update, Orlando, 2016
Self-Help John F. Kelly, Ph.D. Elizabeth R. Spallin Associate Professor in Psychiatry Harvard Medical School Director Recovery Research Institute Program Director Addiction Recovery Management Service
More informationLessons learned from 15 years of NIH funded 12 step Mechanisms of Behavior Change Research: Implications for treatment and recovery
Lessons learned from 15 years of NIH funded 12 step Mechanisms of Behavior Change Research: Implications for treatment and recovery John F. Kelly, Ph.D. & Robert L. Stout, Ph.D. RSA, MOBC Satellite, June,
More informationJohn F. Kelly, Ph.D. The Role of AA in Mobilizing Adaptive Social Network Changes: A Prospective Lagged Mediational Analysis
The Role of AA in Mobilizing Adaptive Social Network Changes: A Prospective Lagged Mediational Analysis John F. Kelly, Ph.D. Massachusetts General Hospital & Harvard Medical School SSA Symposium, York,
More informationThe Protective Wall of Human community: The new science on recovery mutual-help organizations
The Protective Wall of Human community: The new science on recovery mutual-help organizations John F. Kelly, Ph.D. Elizabeth R. Spallin Associate Professor in Psychiatry Harvard Medical School Director
More information10/29/2015. Clinical Implications and Applications of the Research on Twelve-Step Facilitation and mutual-help organizations
Clinical Implications and Applications of the Research on Twelve-Step Facilitation and mutual-help organizations John F. Kelly, Ph.D. Elizabeth R. Spallin Associate Professor in Psychiatry Harvard Medical
More informationJohn F. Kelly, PhD, ABPP Massachusetts General Hospital Harvard Medical School.
John F. Kelly, PhD, ABPP Massachusetts General Hospital Harvard Medical School 1970 During the past 50 yrs since War on Drugs declared, we have moved from Public Enemy No. 1 to Public Health Problem No.
More informationCognitive Behavioral Therapy (CBT) for Substance Use Disorder
Cognitive Behavioral Therapy (CBT) for Substance Use Disorder John F. Kelly, Ph.D. 1 Disclosures Neither I nor my spouse/partner has a relevant financial relationship with a commercial interest to disclose.
More informationThe age of feeling in-between : Factors that influence emerging adult outcomes during and after residential substance use disorder treatment
The age of feeling in-between : Factors that influence emerging adult outcomes during and after residential substance use disorder treatment Brandon G. Bergman, PhD Associate Director & Research Scientist,
More informationCognitive Behavioral Therapy (CBT) for Substance Use Disorder
Cognitive Behavioral Therapy (CBT) for Substance Use Disorder John F. Kelly, Ph.D. 1 Cognitive Behavioral Therapy (CBT) What is CBT and its assumptions? What are the clinical strategies involved in CBT?
More informationCan 12 Step and Medications for Substance Use Disorders Co-Exist?
Can 12 Step and Medications for Substance Use Disorders Co-Exist? Laura G. Kehoe, MD, MPH Medical Director, Substance Use Disorders Unit Bridge Clinic Massachusetts General Hospital Overview Brief overview
More informationAA Effectiveness Faith Meets Science
AA Effectiveness Faith Meets Science Lee Ann Kaskutas, Dr.P.H. Alcohol Research Group, Emeryville, CA School of Public Health, UC Berkeley East Bay Community Recovery Project June 26, 2007 Oakland, California
More informationContemporary Psychiatric-Mental Health Nursing Third Edition
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 28 Therapeutic Groups Therapeutic Groups Many goals we set for ourselves cannot be achieved without membership in groups and families;
More informationIs Alcoholics Anonymous Effective?
EDITORIAL Is Alcoholics Anonymous Effective? Alcoholics Anonymous (AA) is a world wide organization that is a social support group for people with a desire to quit alcohol. The primary purpose of the organization
More informationNational Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says
National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says Last Updated February 2016 https://www.drugabuse.gov 1 Table of Contents Understanding Drug Abuse and Addiction:
More informationCouncil on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain
Council on Chemical Abuse Annual Conference November 2, 2017 The Science of Addiction: Rewiring the Brain David Reyher, MSW, CAADC Behavioral Health Program Director Alvernia University Defining Addiction
More informationOpioid Use Disorder Treatment Initiation in Diverse Settings
Opioid Use Disorder Treatment Initiation in Diverse Settings Sarah Wakeman, MD, FASAM Medical Director, Mass General Substance Use Disorder Initiative Assistant Professor, Harvard Medical School Disclosures
More informationHelping Behaviors and Alcohol Use Disorders
Helping Behaviors and Alcohol Use Disorders Maria E. Pagano, Ph.D. Assistant Professor of Psychiatry Case Western Reserve University Medical School Copyright Alcohol Medical Scholars Program 1 This Lecture
More informationTwelve Step Facilitation (TSF) Twelve Step Facilitation for Co-occurring Disorders (TSF-COD)
Twelve Step Facilitation (TSF) and Twelve Step Facilitation for Co-occurring Disorders (TSF-COD) SCOPE AND SEQUENCE Evidence-Based Programs from For more information about these programs, visit hazelden.org/bookstore
More informationMOTIVATIONAL INTERVIEWING. Evidence-Based Behavioral Therapy for Addictions. Therapies
Evidence-Based Behavioral Therapy for Addictions Chris Farentinos, MD, MPH, CADC II Director Behavioral Health Legacy Therapies Motivational Interviewing (MI) Cognitive Behavioral Therapy (CBT) Dialectical
More informationNIH Public Access Author Manuscript J Addict Dis. Author manuscript; available in PMC 2009 September 18.
NIH Public Access Author Manuscript Published in final edited form as: J Addict Dis. 2009 ; 28(2): 145 157. doi:10.1080/10550880902772464. Alcoholics Anonymous Effectiveness: Faith Meets Science Lee Ann
More informationTHE CHRONIC DISEASE OF ADDICTION. J.A. Samander, M.D.
THE CHRONIC DISEASE OF ADDICTION J.A. Samander, M.D. OBJECTIVES Review of chronic, relapsing model of addiction Comparison with other chronic diseases Lessons from patients Addiction 24.6 million adults
More informationThe Importance of Psychological Treatment and Behavioral Support
The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding
More informationWhat is addiction and what can businesses do about it?
What is addiction and what can businesses do about it? Michael M. Miller, MD, DFASAM, DLFAPA Director of Addition Program Development and Training Rogers Behavioral Health Business Health Care Group April
More information12-step participation among polysubstance users
12-step participation among polysubstance users Longitudinal patterns, effectiveness, and (some) mechanisms of action Alexandre B. Laudet, Ph.D Research Society on Alcoholism, June 2008, Washington DC
More informationEffectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use. Chad Morris, PhD March 7, 2018
Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use Chad Morris, PhD March 7, 2018 2018 BHWP Behavioral Causes of Death in U.S. 2018 BHWP 2018 BHWP Health Disparities Population Behavioral
More informationAlcoholics Anonymous and other 12-step programmes for alcohol dependence
[Intervention Review] Alcoholics Anonymous and other 12-step programmes for alcohol dependence Marica MF Ferri 1, Laura Amato 2, Marina Davoli 3 1 Project Unit: EBM and Models of Health Assistance, Agency
More informationThe MGH Substance Use Disorder Initiative Sarah E. Wakeman, MD, FASAM Medical Director Assistant Professor of Medicine, Harvard Medical School
The MGH Substance Use Disorder Initiative Sarah E. Wakeman, MD, FASAM Medical Director Assistant Professor of Medicine, Harvard Medical School Disclosures Neither I nor my spouse/partner has a relevant
More informationOUTPATIENT TREATMENT WESTPORT, CONNECTICUT
OUTPATIENT TREATMENT WESTPORT, CONNECTICUT ABOUT CLEARPOINT At Clearpoint, we focus on healing the whole person: mind, body, and spirit. Our comprehensive care methods set clients up for long-term success
More informationFacing Addiction with Science and Recovery
Facing Addiction with Science and Recovery By H. Westley Clark, MD, JD, MPH 2 Five Overarching Messages 1. Both substance misuse and substance use disorders harm the health and well being of individuals
More informationNoel Schenk MD. Davis Behavioral Health
Noel Schenk MD Davis Behavioral Health Michael Botticelli Director of National Drug Control Policy What is Addiction? Addiction is defined as a chronic, relapsing brain disease that is characterized by
More informationOverview of Adolescent Substance Abuse & Treatment
Overview of Adolescent Substance Abuse & Treatment Joan E. Zweben, Ph.D. Executive Director, EBCRP Clinical Professor of Psychiatry, UCSF PREP Program Training June 23, 2011 Adolescent Substance Use Critical
More informationCharacteristics 9/26/2014. Neurocognitive Dysfunction and Treatment Targets in Gambling
Neurocognitive Dysfunction and Treatment Targets in Gambling Jon E. Grant, JD, MD, MPH Professor, University of Chicago Source: Look Magazine, March, 1963 Characteristics Age: usually begins in early adulthood
More informationA MULTI-LAYERED APPROACH TO RECOVERY: VETERAN AND MILITARY FAMILY CASE EXAMPLES
A MULTI-LAYERED APPROACH TO RECOVERY: VETERAN AND MILITARY FAMILY CASE EXAMPLES Heather Kapson, PhD Ann Stewart, LICSW September 18, 2017 DISCLOSURES None HOME BASE PROGRAM Red Sox Foundation and Massachusetts
More information2/19/18. Today s talk. Today s talk. The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders
The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA Professor of Psychiatry,
More informationAddiction as a Neuropsychiatric Medical Condition
Addiction as a Neuropsychiatric Medical Condition Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse 5 November 2009 Summary
More informationNeurobiology of Addiction
Neurobiology of Addiction Tiffany Love, Ph.D. Department of Psychiatry The University of Utah What is Addiction? Addiction is a chronic, relapsing, and treatable brain disorder. Compulsive drug seeking
More informationUnderstanding Addiction
Understanding Addiction How Addiction Hijacks the Brain Addiction involves craving for something intensely, loss of control over its use, and continuing involvement with it despite adverse consequences.
More informationSubstance Abuse Group Therapy
Substance Abuse Group Therapy Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Chapter 1 This natural propensity in humans makes group therapy a powerful
More informationBEHAVIORAL HEALTH SERVICES Treatment Groups
BEHAVIORAL HEALTH SERVICES Treatment Groups MOTIVATIONAL ENHANCEMENT GROUP This eight week group is design to assist individuals in resolving the ambivalence that is typical and predictable by anyone faced
More informationThe Matrix Model in the New Healthcare World: Implementing EBPs
The Matrix Model in the New Healthcare World: Implementing EBPs Ahndrea Weiner M.S., LMFT, LPCC Director of Training Matrix Institute on Addictions History of The Matrix Model Traveling Back to the 1980
More informationBrain Images Reveal First Physical Evidence that Prayers Reduce Cravings in Alcoholics Anonymous Members
Brain Images Reveal First Physical Evidence that Prayers Reduce Cravings in Alcoholics Anonymous Members SHARE: MAY 3, 2016 (4:00PM) Longtime members of Alcoholics Anonymous (AA) often report little or
More informationGreat Debates Evidence-Based Practice: Specific Methods and/or Therapeutic Relationship?
9/28/217 Great Debates Evidence-Based Practice: Specific Methods and/or Therapeutic Relationship? Scott D. Miller and William R. Miller Presentation slides from William Miller Increasing pressure to use
More information6/6/2018. Objectives. Outline. Rethinking Medication Treatment for Opioid Use Disorder
Rethinking Medication Treatment for Opioid Use Disorder International Conference on Opioids June 10, 2018 Dustin Patil, MD Fellow, Addiction Psychiatry Boston Medical Center John Renner, MD Professor of
More informationThe Impaired Professional. Peter Cohen, D.O.
The Impaired Professional Peter Cohen, D.O. Definition The American Medical Association (AMA) defines impairment as the inability to practice medicine with reasonable skill and safety to patients by reason
More informationV. EVIDENCE-BASED APPROACHES TO TREATING ADOLESCENT SUBSTANCE USE DISORDERS
V. EVIDENCE-BASED APPROACHES TO TREATING ADOLESCENT SUBSTANCE USE DISORDERS R esearch evidence supports the effectiveness of various substance abuse treatment approaches for adolescents. Examples of specific
More informationOverview. An Old But Important Dilemma 10/24/12. The Role of the Clinician in Creating Confidence in Care
The Role of the Clinician in Creating Confidence in Care Theresa B. Moyers, Ph.D. Department of Psychology Center on Alcoholism, Substance Abuse and Addictions (CASAA) University of New Mexico Overview
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationWhat are Substance Use Disorders?
What are Substance Use Disorders? Sanchit Maruti, MD Michael Goedde, MD University of Vermont Medical Center 1 Disclosures } Drs. Maruti and Goedde receive compensation as consultants to the American Academy
More informationAlcoholics Anonymous Effectiveness: Faith Meets Science
Alcoholics Anonymous Effectiveness: Faith Meets Science Lee Ann Kaskutas, DrPH ABSTRACT. Research on the effectiveness of Alcoholics Anonymous (AA) is controversial and subject to widely divergent interpretations.
More informationPossession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no
Dr. Joseph Garbely Medical Director VP of Medical Services Caron Treatment Centers 1 ASAM Disclosure of Relevant Financial Relationships No Relevant Financial Relationships with Any Commercial Interests
More informationMedication Supported Recovery- A Review of Evidence-Based Practice
Medication Supported Recovery- A Review of Evidence-Based Practice Andrew B. Mendenhall, MD, DABAM, DABFM, Senior Medical Director, Substance Use Disorder Services, Central City Concern 1 Objectives 1.
More informationReducing Stigma and improving access to Drug and Alcohol Treatment. Presented by: Jim Scarpace ; LCPC
Reducing Stigma and improving access to Drug and Alcohol Treatment Presented by: Jim Scarpace ; LCPC Who is Gateway Alcohol & Drug Treatment? Largest Provider of Substance Abuse Treatment in Illinois Locations
More information4/5/2018 MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS OBJECTIVES DEFINITION OF ADDICTION APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H.
MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H. MEDICAL DIRECTOR, UNITYPOINT HEALTH MERITER/ NEWSTART ADJUNCT PROFESSOR, UNIVERSITY OF WISCONSIN MADISON
More informationPeople Powered Digital Health Solutions
People Powered Digital Health Solutions 1 DISCLOSURE 2 LEARNING & EVALUATION LEARNING OBJECTIVES EVALUATION 3 AA, 2001, p. 124 4 5 Alcohol accounts for 70% of substance abuse 14.3% of Children 8.4% of
More informationOT Interventions and Substance Abuse
OT Interventions and Substance Abuse By Rick Klimowicz, MDiv MHS OTR/L Objectives Consider a recent narrative review on psychosocial OT interventions for Substance Use Disorders Consider how to adapt or
More informationBrief Interventions/Brief Therapies for Substance Abuse
Brief Interventions/Brief Therapies for Substance Abuse Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Chapter 1 Brief interventions and therapies can
More informationFacing Addiction: Key Terms Use Any use of any substance. Driven by market forces. Misuse Use that can harm self or others. Driven by consequences.
Facing Addiction: Surgeon General s Report on Reducing Misuse and Addiction A.Thomas McLellan Senior Editor Key Terms Use Any use of any substance. Driven by market forces Misuse Use that can harm self
More informationBlending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings
William R. Miller, Ph.D. The University of New Mexico Have you noticed: that in multisite trials (like CTN) of treatments that are already evidence-based even under highly controlled, supervised, manual
More informationFoundations of Addictions
Foundations of Addictions Week 8 Glenn Maynard, LPC Addiction as a maladaptive behavior This approach is grounded in psychology Model comes from classical conditioning, operative conditioning and social
More informationTreating Addictive Disorders with Cognitive Behavioral Therapy (CBT)
Treating Addictive Disorders with Cognitive Behavioral Therapy (CBT) James McKowen, Ph.D. Addiction Recovery Management Service (ARMS) Orlando, FL 2016 Disclosures Neither I nor my spouse/partner has a
More informationIDDT Fidelity Action Planning Guidelines
1a. Multidisciplinary Team IDDT Fidelity Action Planning Guidelines Definition: All clients targeted for IDDT receive care from a multidisciplinary team. A multi-disciplinary team consists of, in addition
More informationRecovery as an issue of social justice and social inclusion
Recovery as an issue of social justice and social inclusion Professor David Best Sheffield Hallam University / Monash University November 2016: Copenhagen The central values of the centre: widening access
More informationDMHAS ASAM SERVICE DESCRIPTIONS
(DMHAS) Fee for Service (FFS) ANNEX A1 DMHAS ASAM SERVICE DESCRIPTIONS Please carefully review the Service Descriptions that are included in the DMHAS FFS Initiatives in this Annex A1 contract section.
More informationIf gambling treatment was evidence based, what would it look like?
If gambling treatment was evidence based, what would it look like? Professor Mark Griffiths International Gaming Research Unit Nottingham Trent University E-mail : mark.griffiths@ntu.ac.uk Website :http://ess.ntu.ac.uk/griffiths
More informationEvidence based Practices
Evidence base Practices Adjunct Professor of Psychology, Western Carolina University President, Evince Clinical Assessments Evidence based Treatment Utilize treatment models documented to be effective
More informationAmerican Addiction Centers Outcomes Study Long-Term Outcomes Among Residential Addiction Treatment Clients. Centerstone Research Institute
American Addiction Centers Outcomes Study Long-Term Outcomes Among Residential Addiction Treatment Clients Centerstone Research Institute 2018 1 AAC Outcomes Study: Long-Term Outcomes Executive Summary
More informationWHAT ARE SOME BEHAVIORAL STRATEGIES TO HELP MY PATIENT STAY SOBER?
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences WHAT ARE SOME BEHAVIORAL STRATEGIES TO HELP MY PATIENT STAY SOBER? MARK DUNCAN MD ADD RELAPSE PREVENTION PLAN SPEAKER
More informationRecovery as an issue of social justice and social inclusion. Professor David Best Sheffield Hallam University / Monash University
Recovery as an issue of social justice and social inclusion Professor David Best Sheffield Hallam University / Monash University The central values of the centre: widening access to jus4ce promo4on of
More informationYoung Adults, Social Networks, and Addiction Recovery: Post Treatment Changes in Social Ties and Their Role as a Mediator of 12-Step Participation
Young Adults, Social Networks, and Addiction Recovery: Post Treatment Changes in Social Ties and Their Role as a Mediator of 12-Step Participation The Harvard community has made this article openly available.
More informationAntipathy or Naivety?
Antipathy or Naivety? Professor Jonathan Chick, Consultant Psychiatrist Declaration of interests: Visiting Professor, Napier University, Edinburgh Medical Director, Castle Craig Hospital, Scottish Borders
More informationThe role of behavioral interventions in buprenorphine treatment of opioid use disorders
The role of behavioral interventions in buprenorphine treatment of opioid use disorders Roger D. Weiss, MD Harvard Medical School, Boston, MA, McLean Hospital, Belmont, MA, USA Today s talk Review of studies
More informationBrain Health and Opioid Abuse
2018 Statewide Tribal Opioid Summit Brain Health and Opioid Abuse Healing From Opiate Addiction Requires Comprehensive Approaches Psychological, Socio-Cultural, and Biological Donald R. Vereen, Jr., M.D.,
More information11/7/2016. Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no
Dean Drosnes, MD, FASAM Associate Medical Director Caron Treatment Centers ASAM Disclosure of Relevant Financial Relationships Date of Activity: Nov 3, 2016 Name Commercial Interests Relevant Financial
More informationEvidence-Based Treatment Approaches for Gambling Disorder
Evidence-Based Treatment Approaches for Gambling Disorder Jon E. Grant, JD, MD, MPH Professor University of Chicago Pritzker School of Medicine Chicago, IL 6/8/2016 Disclosure Information My research is
More informationSubstance Abuse Suboxone Treatment
Substance Abuse Suboxone Treatment Program Waterbury Hospital Infectious Disease Clinic Richard Smith, LCSW Leonard Savage, Consumer Steven I. Aronin, MD FACP, Program Director Ryan White All Grantee Meeting
More informationWHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS
WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS René Lento, PhD Lauren Brenner, PhD September 25, 2018 DISCLOSURES None HOME BASE PROGRAM 3 LEARNING OBJECTIVES
More informationThe Treatment of Illicit Drug Taking
The Treatment of Illicit Drug Taking David A. Deitch, Ph.D. University of California San Diego Clinical Professor of Psychiatry and Director, Addiction Training Center 1 Alcohol Vs. Illicit Drugs and the
More informationSelf Management And Recovery Training Discover the Power of Choice
ICADD Tuesday, May 13, 2014 1:15pm to 3:00pm, Jordan C SMART Recovery (Part A): The Leading Self-empowering Mutual Help Group By Tom Horvath, Ph.D. Handout SMART Recovery is an international non-profit
More informationThe Co-Occurring Disorders Treatment Program
G R O U P D E S C R I P T I O N S The Co-Occurring Disorders Treatment Program is designed to provide a continuum of services to the substance abusing and dually diagnosed populations. These services include
More informationThe Adolescent Developmental Stage
The Adolescent Developmental Stage o Physical maturation o Drive for independence o Increased salience of social and peer interactions o Brain development o Inflection in risky behaviors including experimentation
More informationVOLUME B. Elements of Psychological Treatment
VOLUME B Elements of Psychological Treatment VOLUME B MODULE 1 Drug dependence and basic counselling skills Biology of drug dependence Principles of drug dependence treatment Basic counselling skills for
More informationAdolescent Brain Development and Drug Abuse. Ken C. Winters, Ph.D. Professor, Department of Psychiatry, University of Minnesota
Adolescent Brain Development and Drug Abuse New findings indicate that brain development still in progress during adolescence; immature brain structures may place teenagers at elevated risk of substance
More informationRECOMMENDATIONS FOR HEALTH CARE PROVIDERS
Ending Addiction Changes Everything RECOMMENDATIONS FOR HEALTH CARE PROVIDERS CRITICAL ADDICTION PREVENTION, TREATMENT AND MANAGEMENT SERVICES TO INCLUDE IN ROUTINE HEALTH CARE PRACTICE JULY 2013 In the
More informationDiscover the Hope: Opiate Treatment and Recovery
Discover the Hope: Opiate Treatment and Recovery The Continued Struggle to Find and Implement Best Practices Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of
More informationElizabeth (Libby) A.R. Robinson, Ph.D., MSW, MPH.
Recovery and Spiritual Change: Are They Related? Elizabeth (Libby) A.R. Robinson, Ph.D., MSW, MPH. The Life Transitions Study What were we trying to find out and why How did we measure recovery and spiritual
More informationChapter 7. Screening and Assessment
Chapter 7 Screening and Assessment Screening And Assessment Starting the dialogue and begin relationship Each are sizing each other up Information gathering Listening to their story Asking the questions
More informationBASIC VOLUME. Elements of Drug Dependence Treatment
BASIC VOLUME Elements of Drug Dependence Treatment BASIC VOLUME MODULE 1 Drug dependence concept and principles of drug treatment MODULE 2 Motivating clients for treatment and addressing resistance MODULE
More informationTreatment for Alcohol Problems: Finding and Getting Help
Treatment for Alcohol Problems: Finding and Getting Help This guide is written for individuals, and their family and friends, who are looking for options to address alcohol problems. It is intended as
More informationTreatment of Youth Opioid Addiction: Approaches to a Modern Epidemic. What should we do with this case? Heroin Addiction History
Treatment of Youth Opioid Addiction: Approaches to a Modern Epidemic What should we do with this case? 17 M Onset prescription opioids 15, progressing to daily use with withdrawal within 8 months Onset
More informationPEER SUPPORT SERVICES PROVIDING UTILIZING A RECOVERY ORIENTED SYSTEM OF CARE (ROSC)
PEER SUPPORT SERVICES PROVIDING UTILIZING A RECOVERY ORIENTED SYSTEM OF CARE (ROSC) Pamela Butler COORDINATOR OF RECOVERY SUPPORT SERVICES ALABAMA DEPARTMENT OF MENTAL HEALTH SUBSTANCE ABUSE SERVICE 334-353-4362
More informationHOUSE Calls. Addiction Medicine. Winter Published by the Alachua County Medical Society
HOUSE Calls Published by the Alachua County Medical Society Winter 2017 Addiction Medicine Addiction as a Disease Gregory L. Jones, MD, FASAM, FAAF, UF Health Florida Recovery Center Scott A. Teitelbaum,
More informationApplying Mobile Technology to Mental Health and Substance Use Disorders: The State of the Science
Applying Mobile Technology to Mental Health and Substance Use Disorders: The State of the Science Lisa A. Marsch, PhD Director, Dartmouth Center for Technology and Behavioral Health Director, Northeast
More informationPsychosocial Treatments for Opioid Use Disorder Overview
Psychosocial Treatments for Opioid Use Disorder Overview Nalan Ward, MD Director Outpatient Addiction Services Department of Psychiatry Massachusetts General Hospital *Images used for educational purposes
More informationSocial-Environmental Mechanisms of Behavior Change: A Focus on Support for Abstinence
Social-Environmental Mechanisms of Behavior Change: A Focus on Support for Abstinence Ken Leonard Research Institute on Addictions, University at Buffalo, State University of New York, Buffalo, NY, USA
More informationCenter for Recovering Families
303 Jackson Hill St. Houston, TX 77007 Healing Choices Center for Recovering Families 713.914.0556 303 Jackson Hill Street Houston, TX 77007 713.914.0556 www.councilonrecovery.org Healing Choices Renewed
More informationSyracuse Community Treatment Court. Handbook for Participants. Guidelines and Program Information
Syracuse Community Treatment Court Handbook for Participants Guidelines and Program Information John C. Dillon Public Safety Building 511 South State Street Room 117 Syracuse, New York 13202 PHONE 315-671-2795
More informationJames Finch, MD, FASAM Director of Physician Education NC Governor s Institute on Alcohol and Substance Abuse Medical Director: Changes By Choice
James Finch, MD, FASAM Director of Physician Education NC Governor s Institute on Alcohol and Substance Abuse Medical Director: Changes By Choice Durham, NC ASAM Disclosure of Relevant Financial Relationships
More informationSubstance Use And Addiction Disorders, Parts 3 & 4
Substance Use And Addiction Disorders, Parts 3 & 4 1. Medication Assisted Treatment is: a. used exclusively for marijuana addiction b. the program of choice for chronic relapses c. recommended for multiple
More informationAODA RECOVERY. How to support those in recovery, and those not yet ready to commit
AODA RECOVERY How to support those in recovery, and those not yet ready to commit YOUR PRESENTER TODAY Robin Lickel is a psychotherapist and addictions specialist at Journey Mental Health Center in Madison,
More information